• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 E 的主要成分α-生育酚抑制 EML4-ALK 转化细胞中克唑替尼的抗肿瘤活性。

A major component of vitamin E, α-tocopherol inhibits the anti-tumor activity of crizotinib against cells transformed by EML4-ALK.

机构信息

Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.

Division of Structural Biochemistry, Department of Biochemistry, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi-ken 329-0498, Japan.

出版信息

Eur J Pharmacol. 2018 Apr 15;825:1-9. doi: 10.1016/j.ejphar.2018.02.012. Epub 2018 Feb 11.

DOI:10.1016/j.ejphar.2018.02.012
PMID:29444468
Abstract

Crizotinib is an inhibitor of anaplastic lymphoma kinase (ALK) and is of significant therapeutic benefit to patients with non-small cell lung cancer (NSCLC) harboring the EML4-ALK fusion gene. In the present study, we demonstrated that α-tocopherol, a major component of vitamin E, attenuated the effects of crizotinib independently of its anti-oxidant properties. α-Tocopherol significantly inhibited crizotinib-induced apoptosis in cells transformed by EML4-ALK. It also effectively attenuated the crizotinib-induced inhibition of EML4-ALK and its downstream molecules, STAT3 and ERK, and suppressed the inhibitory effects of crizotinib on EML4-ALK-mediated transformation in the focus formation assay. On the other hand, other members of the vitamin E family, namely, β-tocopherol, γ-tocopherol, δ-tocopherol, and α-tocotrienol, and a water-soluble analog of vitamin E, Trolox had no effects on the anti-tumor activity of crizotinib in cells transformed by EML4-ALK. Collectively, these results revealed the risk of the anti-tumor activity of crizotinib being attenuated when it is administrated in combination with vitamin E supplements containing α-tocopherol as a major component.

摘要

克唑替尼是一种间变性淋巴瘤激酶(ALK)抑制剂,对携带有 EML4-ALK 融合基因的非小细胞肺癌(NSCLC)患者具有显著的治疗益处。在本研究中,我们证明了α-生育酚(维生素 E 的主要成分之一)可独立于其抗氧化特性减弱克唑替尼的作用。α-生育酚可显著抑制 EML4-ALK 转化细胞中克唑替尼诱导的细胞凋亡。它还能有效减弱克唑替尼诱导的 EML4-ALK 及其下游分子 STAT3 和 ERK 的抑制作用,并抑制克唑替尼在焦点形成测定中对 EML4-ALK 介导的转化的抑制作用。另一方面,维生素 E 家族的其他成员,即β-生育酚、γ-生育酚、δ-生育酚和α-生育三烯酚,以及维生素 E 的水溶性类似物 Trolox,对 EML4-ALK 转化细胞中克唑替尼的抗肿瘤活性没有影响。总之,这些结果表明,当与含有α-生育酚(主要成分)的维生素 E 补充剂联合使用时,克唑替尼的抗肿瘤活性可能会减弱。

相似文献

1
A major component of vitamin E, α-tocopherol inhibits the anti-tumor activity of crizotinib against cells transformed by EML4-ALK.维生素 E 的主要成分α-生育酚抑制 EML4-ALK 转化细胞中克唑替尼的抗肿瘤活性。
Eur J Pharmacol. 2018 Apr 15;825:1-9. doi: 10.1016/j.ejphar.2018.02.012. Epub 2018 Feb 11.
2
Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK.α-生育酚减弱了克唑替尼对由NPM-ALK转化的细胞的抗肿瘤活性。
PLoS One. 2017 Aug 14;12(8):e0183003. doi: 10.1371/journal.pone.0183003. eCollection 2017.
3
A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.携带有 EML4-ALK 融合基因的新型人肺腺癌细胞系。
Jpn J Clin Oncol. 2014 Oct;44(10):963-8. doi: 10.1093/jjco/hyu110. Epub 2014 Aug 28.
4
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK.ALK 抑制剂 PF-02341066(克唑替尼)增加了表达 EML4-ALK 的非小细胞肺癌对辐射的敏感性。
Mol Cancer Ther. 2013 May;12(5):696-704. doi: 10.1158/1535-7163.MCT-12-0868. Epub 2013 Feb 26.
5
Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.微环境旁分泌受体的激活触发 EML4-ALK 肺癌细胞旁路存活信号和 ALK 抑制剂耐药。
Clin Cancer Res. 2012 Jul 1;18(13):3592-602. doi: 10.1158/1078-0432.CCR-11-2972. Epub 2012 May 2.
6
Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.与EML4-ALK相比,第二代ALK抑制剂在NPM-ALK模型中对克唑替尼耐药突变体的活性。
Cancer Med. 2015 Jul;4(7):953-65. doi: 10.1002/cam4.413. Epub 2015 Feb 26.
7
Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK.克服携带融合癌基因 EML4-ALK 的非小细胞肺癌对克唑替尼耐药的治疗策略。
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7535-40. doi: 10.1073/pnas.1019559108. Epub 2011 Apr 18.
8
HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.HIP1-ALK,一种新型的 ALK 融合变异体,对克唑替尼有反应。
J Thorac Oncol. 2014 Mar;9(3):285-94. doi: 10.1097/JTO.0000000000000087.
9
Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.ERK-BIM 和 STAT3-survivin 信号通路在 ALK 抑制剂诱导 EML4-ALK 阳性肺癌细胞凋亡中的作用。
Clin Cancer Res. 2011 Apr 15;17(8):2140-8. doi: 10.1158/1078-0432.CCR-10-2798. Epub 2011 Mar 17.
10
Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.靶向干性是控制EML4-ALK+非小细胞肺癌细胞的有效策略。
Oncotarget. 2015 Nov 24;6(37):40255-67. doi: 10.18632/oncotarget.5434.

引用本文的文献

1
The Potential of Natural Compounds in UV Protection Products.天然化合物在防晒产品中的潜力。
Molecules. 2024 Nov 16;29(22):5409. doi: 10.3390/molecules29225409.
2
Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin-Drug Interactions Exist?评估脂溶性维生素补充剂对感染SARS-CoV-2的自身免疫性疾病患者和癌症患者的风险效益比:是否存在维生素与药物的相互作用?
Life (Basel). 2022 Oct 20;12(10):1654. doi: 10.3390/life12101654.